VERV

Verve Therapeutics
VERV

Overview Fund Activity
Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

73 hedge funds and large institutions have $1.81B invested in Verve Therapeutics in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 30 closing their positions.

Holders
73
Holders Change
+4
Holders Change %
+5.8%
% of All Funds
1.28%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
34
Increased
16
Reduced
13
Closed
30
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$60.3M
2
AIM
2
ARK Investment Management
Florida
$59.6M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$214M
4
BlackRock
4
BlackRock
New York
$44.4M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$12.9M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$0
2
Millennium Management
2
Millennium Management
New York
$0
3
LGM
3
Logos Global Management
California
$20.8M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$52.5M
5
NHAS
5
Novo Holdings A/S
Denmark
$28.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
ECM
101
ExodusPoint Capital Management
New York
– -$322K -5,345 Closed
Capstone Investment Advisors
102
Capstone Investment Advisors
New York
– -$301K -5,000 Closed
LC
103
Lindbrook Capital
California
– -$18K -300 Closed
1 2 3 4
5